Table 1.
Functional characterization of human adrenocortical carcinoma samples (n = 13) towards their GNRHR, LHCGR, FSHR mRNA and protein expression, proliferation and hormone secretion.
| Patient number | Sex | Age | Stage (ENSAT) | Size (cm) | Hormone secretion | MKI67 (%) | GNRHR/GNRHR | LHCGR/LHCGR | FSHR/FSHR |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Male | 46 | 2 | 9.5 | Aldosterone | 20 | + | + | − |
| 2 | Female | 60 | 2 | 13 | Androgen | 20 | + | + | − |
| 3 | Female | 30 | 4 | 17 | Androgen | 40 | + | + | − |
| 4 | Female | 72 | 4 | 8 | Cortisol | 20 | − | − | − |
| 5 | Female | 57 | 4 | 12 | Cortisol + androgens | 20 | + | + | − |
| 6 | Male | 31 | 2 | 11 | No clinical evidence | 2 | − | + | − |
| 7 | Female | 40 | 2 | 21.5 | No clinical evidence | 10 | − | − | − |
| 8 | Male | 50 | 2 | 20 | No clinical evidence | 7 | + | + | − |
| 9 | Female | 46 | 3 | 18 | No clinical evidence | 40 | − | + | − |
| 10 | Male | 44 | 4 | 13 | No clinical evidence | 10 | − | − | − |
| 11 | Female | 44 | 4 | 4.5 | Slight cortisol | 50 | + | + | − |
| 12 | Male | 64 | 4 | 16 | Slight cortisol | 10 | − | + | − |
| 13 | Male | 59 | 4 | 5.5 | Slight cortisol + androgen precursors | 10 | + | + | − |
This work is licensed under a